UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 8-K

______________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2021

______________

HEALTHTECH SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

______________

Utah 0-51012 84-2528660
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)

 

90 Broad Street, 16th Floor, New York, New York 10004

(Address of Principal Executive Office) (Zip Code)

 

844-926-3399

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

  1  

 

ITEM 5.02   DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS

On April 24, 2021 Denis Kleinfeld resigned from his position as a member of the Registrant's Board of Directors.

  

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  Healthtech Solutions, Inc.
     

Date: April 29, 2021

 

By:  

/s/ David Rubin

David Rubin, Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

  2  

 

HealthTech Solutions (CE) (USOTC:HLTT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more HealthTech Solutions (CE) Charts.
HealthTech Solutions (CE) (USOTC:HLTT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more HealthTech Solutions (CE) Charts.